BSE · PARMAX.BO
Parmax Pharma Limited
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
Loading market information…
BSE · NORRIS.BO · INR
Stock price
Quote as of Oct 30, 2026, 07:01 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Norris Medicines Limited’s quoted price sits in the lower half of its reported 52-week range, 29.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Norris Medicines Ltd. focuses on the development and production of pharmaceutical compounds, medicinal chemicals, and botanical extracts. Their diverse product range addresses various health concerns, encompassing categories like antibiotics, anti-inflammatory agents, anti-emetics, nutritional supplements, cough and cold remedies, dermatological and allergy treatments, anti-malarial drugs, and medications for diabetic and cardiac conditions. The company, which established its operations in 1990, is based in Ankleshwar, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
₹43.00+₹5.00 (+13.16%)
Novateor Research Laboratories’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
₹130.85₹0.00 (0.0%)
Chemo Pharma Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 13.91% below the high.
₹25.13+₹1.19 (+4.97%)
Span Divergent Limited’s quoted price sits in the lower half of its reported 52-week range, 51.19% below the high.
₹25.00-₹1.18 (-4.51%)
Zenlabs Ethica Limited’s quoted price sits in the lower half of its reported 52-week range, 37.48% below the high.
₹20.39-₹0.01 (-0.05%)
Vanta Bioscience Limited’s quoted price sits in the lower half of its reported 52-week range, 29.69% below the high.
₹5.01₹0.00 (0.0%)
Cian Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.6% below the high.
₹23.36-₹1.64 (-6.56%)
Beryl Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 16.27% below the high.
